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Abstract
Background: We investigated relationship of low levels of high density lipoprotein cholesterol (HDL-C), high levels
of triglycerides, and renal function for the odds, prognosis and survival following acute coronary events among
patients with a first event and normal low density lipoprotein cholesterol levels.
Results: A case-control study based on 557 patients and 1086 matched control subjects was conducted. Case
patients were followed up for survival with a median of 1.9 years. Participants in the higher quintiles of HDL-C had
lower odds to develop acute coronary events (the adjusted odds ratios were 0.24 for the second, 0.24 for the third,
0.10 for the fourth and 0.05 for the fifth quintile). Patients with normal glomerular filtration rate were at a lower risk
for all-cause death. However, a reverse association between triglycerides and death risk was found: patients with
higher triglycerides were at a lower risk for all-cause death (adjusted relative risk, 0.38 for triglycerides ranging from
82 to 132.9 mg/dL, and 0.14 for triglycerides > = 133 mg/dL).
Conclusions: Low HDL-C was significantly associated with acute coronary events, and triglyceride levels as well as
renal function were inversely related to all-cause deaths after the coronary event.
Keywords: acute coronary syndrome, residual risk, dyslipidemia
Introduction
Lipid-related residual risk, including low levels of high
density lipoprotein cholesterol (HDL-C) and high levels
of triglycerides, has become a clinical target since the
availability of aggressive low density lipoprotein choles-
terol (LDL-C) lowering by statin treatment [1-4]. Evi-
dence has shown about 70% increased relative risk
among those with versus without low HDL-C and high
triglycerides [5,6]. In addition, a substantial incremental
risk for further cardiovascular events was still apparent
even in patients with LDL-C levels less than 70 mg/dL
who had high triglycerides and low HDL-C [7,8]. Resi-
dual risk profiles, including low HDL-C and high trigly-
cerides among normal LDL-C, should be considered for
prevention of coronary events [9,10]. It is therefore
necessary to investigate the role of lipid-related residual
risk, including low HDL-C and high triglycerides, for
the risk of the occurrence of coronary events.
In addition, chronic kidney disease status, estimated
by lower glomerular filtration rates, is highly prevalent
in Taiwan, with a prevalence rate of 12% in Taiwanese
adults [11]. Evidence has shown that an association
between poor renal function and cardiovascular diseases
is apparent [12,13]. In addition, the role of lipid residual
risk has not been investigated concurrently with renal
function status in previous studies. Moreover, the data
on the residual risk profiles for all-cause death after cor-
onary events are scanty.
Therefore, it appears important to evaluate the preva-
lence of lipid-related residual risk, determine its associa-
tion with acute coronary syndrome, and investigate
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Taiwanese patients. We investigated associations
between low HDL-C, high triglycerides, and renal func-
tion status, for odds for coronary events among patients
who had suffered from first events and were within nor-
mal LDL-C levels in this retrospective case control
study, matching for age, sex, and LDL-C levels. We also
conducted a cohort follow-up to record their survival
status.
Results
Basic distribution of case-control subjects
Table 1 presents the basic characteristics of the control
subjects and acute coronary syndrome case patients.
Compared with the matched control subjects, the case
patients were more likely to be hypertensive, smokers,
and more likely to have a history of diabetes, stroke,
advanced chronic kidney disease and a higher age, sys-
tolic blood pressure, serum creatinine and estimated
glomerular filtration rates. The distributions of sex,
body mass index, triglycerides and LDL-C were not
statistically different between the case subjects and
controls.
Associations with lipid-related residual risk as well as
glomerular filtration rate and the occurrence of acute
coronary syndrome
The numbers in each quintile of triglycerides, HDL-C, and
estimated glomerular filtration rates for the case subjects
and the multivariable adjusted odds ratios and 95% confi-
dence intervals are listed in Table 2. For HDL-C the
higher the quintile, the lower the odds. Compared with
those in the first quintile, participants in the higher quin-
tiles of HDL-C had lower odds to have acute coronary
events. The multivariable adjusted odds ratios (95% confi-
dence interval [CI]) were 0.24 (0.15 to 0.37) for the second,
0.24 (0.15 to 0.38) for the third, 0.10 (0.05 to 0.18) for the
fourth and 0.05 (0.03 to 0.11) for the fifth quintile (test for
trend, P < 0.0001). Adjustment for clinical covariates did
not appreciably change the association. For triglycerides,
the age, sex-adjusted odds ratio for participants with the
highest quintile was 1.55 (95% CI, 1.11 to 2.17), compared
with those in the lowest quintile (test for trend, P = 0.031).
However, the odds ratios for triglycerides attenuated mod-
estly after multiple adjustments. With regards to glomeru-
lar filtration rate, participants in the higher quintiles
were at lower odds for acute coronary syndrome events
Table 1 Basic characteristics of the study participants
Control subjects, n = 1086 Case patients, n = 557
N% N % P
Gender 0.77
Men 800 73.7 414 74.3
Women 286 26.3 143 25.7
Hypertension 129 11.9 402 72.3 <.0001
Diabetes mellitus 51 4.7 213 38.3 <.0001
Smoking 102 9.4 163 29.3 <.0001
Alcohol drinking 600 55.3 144 25.9 <.0001
Old stroke 7 0.6 58 10.4 <.0001
Hypolipidemic medication 121 11.1 185 33.2 <.0001
Glomerular filtration rate, ml/min/1.73 m
2 <.0001
< = 60 215 19.8 188 37.1
60.1-90 787 72.5 246 48.5
> 90 84 7.7 73 14.4
Mean SD Mean SD
Age, yr 64.3 10.6 67.5 9.6 <.0001
BMI, kg/m
2 24.4 3.0 24.7 3.7 0.07
Systolic BP, mmHg 124.8 14.1 135.7 26.0 <.0001
Diastolic BP, mmHg 72.4 9.2 73.1 16.0 0.36
Total cholesterol, mg/dL 177.7 27.6 162.6 31.8 <.0001
Triglycerides, mg/dL 126.3 84.6 133.1 99.9 0.17
HDL cholesterol, mg/dL 44.5 11.2 34.7 11.9 <.0001
LDL cholesterol, mg/dL 97.5 22.1 95.5 23.0 0.10
Serum creatinine, mg/dL 1.12 0.45 1.52 1.47 <.0001
Estimated glomerular filtration rate, ml/min/1.73 m
2 70.0 15.0 64.6 25.6 <.0001
BMI: body mass index; BP: blood pressure; HDL: high density lipoprotein; LDL, low density lipoprotein;
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filtration rate quintile was significantly associated with the
odds for acute coronary syndrome events after multiple
adjustments (odds ratio, 1.92, 95% CI, 1.12 to 3.28), com-
pared with those in the lowest quintile.
To investigate obesity as an effect modifier for the asso-
ciation between triglycerides and acute coronary syn-
drome, we performed subgroup analysis according to body
mass status (Table 3). Among participants with a lower
body mass index (< 24.4 kg/m
2), the odds of acute coron-
ary syndrome increased as the triglyceride quintile
increased (adjusted odds ratio, 1.77, 95% CI, 1.00 to 3.13
for the highest quintile, compared with those with the
lowest triglyceride quintile); however, the direction was
inverse for those with a higher body mass index (> = 24.4
kg/m
2). The interaction between body mass index and tri-
glycerides for the odds of coronary event was significant
(P = 0.046).
Table 2 The number of case control subjects according to lipid quintiles and adjusted odds ratios in the study
participants
Q1 Q2 Q3 Q4 Q5 P
HDL cholesterol, mg/dL <.0001
Range < 35 35-39.9 40-45.9 46-52.9 > = 53
Median 30 37 42 48 60
Control 191 222 235 211 227
Cases 310 99 75 38 21
Odds ratio OR 95% CI OR 95% CI OR 95% CI OR 95% CI Trend
Model 1 1 0.28 0.21 0.38 0.19 0.13 0.26 0.10 0.07 0.15 0.05 0.03 0.09 <.0001
Model 2 1 0.30 0.22 0.43 0.23 0.16 0.33 0.12 0.08 0.19 0.06 0.04 0.11 <.0001
Model 3 1 0.24 0.15 0.37 0.24 0.15 0.38 0.10 0.05 0.18 0.05 0.03 0.11 <.0001
Triglycerides, mg/dL 0.38
Range < 67 67-89.9 90-120.9 121-166.9 > = 167
Median 53 78 104 140 220
Control 211 221 216 216 222
Cases 91 123 106 103 129
Odds ratio OR 95% CI OR 95% CI OR 95% CI OR 95% CI Trend
Model 1 1 1.33 0.95 1.86 1.20 0.85 1.69 1.21 0.86 1.71 1.55 1.11 2.17 0.031
Model 2 1 1.33 0.90 1.95 1.12 0.75 1.67 0.90 0.60 1.35 1.10 0.73 1.64 0.70
Model 3 1 1.12 0.67 1.86 0.87 0.52 1.45 0.56 0.32 0.98 0.76 0.45 1.30 0.12
Glomerular filtration rate <.0001
Range < 60 60-67.7 67.8-73.7 73.8-81.2 > = 81.3
Median 48.0 64.8 71.7 77.3 89.1
Control 217 217 218 217 217
Cases 190 56 58 70 133
Odds ratio OR 95% CI OR 95% CI OR 95% CI OR 95% CI Trend
Model 1 1 0.32 0.22 0.46 0.32 0.22 0.46 0.42 0.30 0.59 0.84 0.61 1.16 0.06
Model 2 1 0.31 0.20 0.47 0.35 0.23 0.53 0.43 0.29 0.64 0.90 0.62 1.31 0.31
Model 3 1 0.39 0.21 0.73 0.49 0.27 0.88 1.01 0.58 1.77 1.92 1.12 3.28 0.010
HDL: high density lipoprotein; LDL, low density lipoprotein
Model 1: adjusted for age & gender
Model 2: additional body mass index, smoking and drinking status
Model 3: additional hypertension, diabetes and estimated filtration rates for lipids as well as triglycerides & HDL cholesterol for filtration rates;
Table 3 Subgroup analysis by obesity status* for the risk of acute coronary syndrome events in the study participants
Q1 Q2 Q3 Q4 Q5 P
Triglycerides 0.046
Odds ratio OR 95% CI OR 95% CI OR 95% CI OR 95% CI Test for trend One quintile
BMI < 24.4 1 1.73 1.06 2.82 1.65 0.97 2.79 1.53 0.88 2.67 1.77 1.00 3.13 0.15 0.09
BMI > = 24.4 1 0.85 0.45 1.59 0.67 0.37 1.24 0.51 0.28 0.94 0.69 0.39 1.24 0.28 0.10
BMI: body mass index; OR: odds ratio; CI: confidence interval;
Interaction between triglycerides & BMI, p = 0.046
* BMI cutoff point = 24.4 kg/m
2
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syndrome
After an average of 2.1 years (median: 1.9, inter-quartile
range: 1.1-3.0) of follow-up among 1086 patients, 39 cases
died, including 10 due to cardiovascular deaths. Table 4
presents the results from a multiple Cox regression model
for the risk of all-cause death after acute coronary syn-
drome events. We found that only glomerular filtration
rates and triglycerides were significant predictors for mor-
tality after acute coronary syndrome. Compared with those
with a glomerular filtration rate < 60 ml/min/1.73 m
2,
patients with filtration rates ranging from 60 to 89.9 and >
= 90 ml/min/1.73 m
2 were at a lower risk for all-cause
death (adjusted relative risk, 0.19 [95% CI, 0.08 to 0.45] and
0.26 [95% CI, 0.06 to 0.19]). In addition, an reverse associa-
tion between triglycerides and death risk for patients with
first coronary events was found. Compared with those with
low triglycerides (< 82 mg/dL), patients with high triglycer-
ides had a lower risk for death (adjusted relative risk, 0.38,
[95%CI, 0.18 to 0.83] for triglyceride levels ranging from 82
to 132.9 mg/dL, and 0.14 [95% CI, 0.05 to 0.43] for trigly-
ceride levels > = 132 mg/dL). The spline associations
between HDL-C, triglycerides and glomerular filtration
rates were plotted accordingly. HDL-C was inversely asso-
ciated with an acute coronary syndrome event, however,
HDL-C was not related to death after the event (Figure 1).
In contrast, high triglycerides were not related to the occur-
rence of a coronary event, although triglycerides were
inversely related to death after the event (Figure 2). Finally,
although glomerular filtration rate was not associated with
coronary events, a high filtration rate was a protective fac-
tor for death after a coronary event (Figure 3).
Discussion
In this matched case-control and cohort study among
patients with first-event acute coronary syndrome and
normal LDL-C levels, we demonstrated that increasing
HDL-C was associated with lower odds for acute coron-
ary syndrome events. HDL-C has been proven to be a
protective factor for coronary artery disease. Epidemiolo-
gical studies such as the Framingham Study [14] and the
Prospective Cardiovascular Münster (PROCAM) study
[15] have established that a low HDL-C is an indepen-
dent risk factor for coronary events. Among the patients
hospitalized due to coronary artery disease, low HDL-C
was highly prevalent, with a prevalence rate of up to 55%
[16]. In addition, a low HDL-C level implies a high ratio
of atherogenic apoB-containing lipoproteins to athero-
protective apoA-I [17,18]. Low HDL-C is prevalent across
all LDL-C levels, particularly so among patients with
LDL-C levels less than 70 mg/dL, even with statin ther-
apy (64%)[18]. Our study implies a significant inverse
association of HDL-C for the odds of acute coronary syn-
drome among patients with normal LDL-C levels.
However, our data did not support an independent
association between triglycerides and coronary events,
after controlling for obesity and clinical disease status. A
meta-analysis based on 10, 158 cases of coronary events
from 262, 525 subjects in 29 studies showed a summar-
ized odds ratio of 1.72 (95%CI 1.56-1.90) in a compari-
son of individuals in the top third with those in the
bottom third oftriglycerides [19]. However, the role of
fasting triglycerides as the risk factor was still controver-
sial. In addition, evidence has favored postprandial tri-
glycerides, instead of fasting triglycerides, as the better
predictor for coronary events [20,21]. Although past evi-
dence on combined low HDL-C and high triglycerides,
“atherogenic dyslipidemia” predicting cardiovascular risk
are available, our results did not support this hypothesis
regarding the joint associations between HDL-C, trigly-
cerides, and acute coronary events. The association was
greatly attenuated after obesity and renal function were
incorporated into the model, implying that the associa-
tion between dyslipidemia and acute coronary events
Table 4 The multiple Cox regression model for the risk of all-cause death among patients with first acute coronary
syndrome events and normal LDL cholesterol levels
Covariates Relative risk 95% CI P
Gender, women vs. men 0.77 0.35 1.73 0.53
Age, 60-74.9 vs. 50-59.9 yrs 1.70 0.47 6.23 0.42
Age, > = 75 vs. 50-59 yr 2.96 0.79 11.05 0.11
History of hypertension 1.16 0.50 2.68 0.73
History of type 2 diabetes 1.17 0.57 2.39 0.68
Glomerular filtration rate, 60-89.9 vs. 60, ml/min/1.73 m
2 0.19 0.08 0.45 0.0002
Glomerular filtration rate, > = 90 vs. 60, ml/min/1.73 m
2 0.26 0.06 1.19 0.08
HDL cholesterol, 38-47.9 vs. < 38 mg/dL 0.53 0.23 1.24 0.14
HDL cholesterol, > = 48 vs. < 38 mg/dL 0.18 0.03 1.37 0.10
Triglycerides, 82-132.9 vs. < 82 mg/dL 0.38 0.18 0.83 0.015
Triglycerides, > = 133 vs. < 82 mg/dL 0.14 0.05 0.43 0.001
HDL: high density lipoprotein; LDL, low density lipoprotein
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tion status.
Evidence showing robust associations between
increasing fasting trigylcerides and declining HDL-C/
tirglyceride ratios with cardiovascular risk has been
derived from prospective studies based on commu-
nities and hospitals [9,19,22,23], and our hosptial-
based case-control study results were consistent to
previous findings. In addition, our further follow-up
study showed that unexpected findings for the risk of
all-cause deaths among patients who suffered from
acute coronary events and had a normal LDL-C level.
The patterns of statistical significance of the associa-
tions between triglycerides, odds for acute coronary
syndrome, and mortality risk may be attributed from
the following reasons. First, lipid-related residual risk
is associated with acute coronary syndrome events,
after which the patients develop wasting and then low
triglycerides may affect survival [24]. Recent evidence
has shown that traditional atherosclerotic risk factors,
such as obesity and lipid levels, are inversely associated
with survival in patients with congestive heart failure
and chronic diseases [24-26]. Second, body fat changes
after the event, such as obesity distribution, inflamma-
tory processes and endotoxin-lipoprotein interaction,
may contribute to the role of triglycerides, which are
highly associated with obesity status, as an inverse
relationship to death among patients with chronic dis-
eases [27]. The interrelationshipe between obesity and
triglycerides after coronary events may account for the
attenuation of the association between triglyceride
levels and coronary risk.
Our previous study based on healthy adults showed
that renal function deterioration was related to cardiovas-
cular and all-cause death mortality, and that the effect
was additive with the metabolic syndrome components
[13]. In addition, a poor prognosis, including increased
cardiovascular disease mortality, is associated with renal
failure in chronic diseases [28-31]. The present study
further demonstrated that poor renal function is also a
Figure 1 Relationship between HDL-C concentrations and the risk of acute coronary syndrome event (left) and all-cause death after
event (right). The multivariate adjusted relative risks were plotted as a function of the baseline HDL-C value with the 95% confidence bands
shown as the shaded area.
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syndrome events. Therefore, identifying poor renal func-
tion and aggressively controlling the progress of renal
function deterioration is crucial for improving the survi-
val in patients experiencing a first coronary event.
This study has some limitation s .F i r s t ,o u rr e s u l t sa r e
only applicable to middle-age and older patients with a
normal LDL-C level due to the study design. Second,
the problem of un-comparability of statin usages
between cases and controls (20% in case patients and
8% in control subjects) may bias the association
between lipid profiles and coronary events. Third, the
follow-up period was relatively short, so the results are
suitable for short-term prognosis and survival. In addi-
tion, we didn’t specify the cause-specific death in the
outcome assessment because of limited death cases
due to cardiovascular events. Assessing all-cause mor-
tality after acute cardiovascular events is a feasible way
to evaluate the prognosis for secondary prevention
[32].
Conclusion
In conclusion, low HDL-C was significantly associated
with acute coronary events, and triglyceride levels as
well as renal function were inversely related to all-cause
deaths after the coronary events. Further secondary pre-
vention studies on the relationship between lipids, renal
function and coronary events may be warranted.
Methods
Study design and study participants
We divided this study into two parts. The first was a
retrospective matched case-control study designed to
examine the association between low HDL-C and high
triglycerides, and the occurrence of acute coronary syn-
drome. The second was a longitudinal cohort study, fol-
lowing up the patients with acute coronary syndrome
until December 31, 2009. The protocol was approved by
the IRB, National Taiwan University Hospital, and writ-
ten informed consent was not obtained due to chart
review and un-labelling participants’ identificiation.
Figure 2 Relationship between triglyceride concentrations and the risk of acute coronary syndrome event (left) and all-cause death
after event (right). The multivariate adjusted relative risks were plotted as a function of the baseline triglyceride value with the 95% confidence
bands shown as the shaded area.
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The matched case-control study design was modified
from the protocol of a multinational, multicenter case-
control study [33]. In brief, patients hospitalized due to
acute coronary syndrome, including unstable angina, ST
elevated myocardial infarction and non-ST elevated myo-
cardial infarction, from 2006 to 2009 were included.
From a retrospective chart review, patients with high
LDL-C (> = 130 mg/dL) were excluded and we limited
the age range to 50 to 85 years. Cases were defined as
patients with a first coronary event (acute coronary syn-
drome, including myocardial infarction) admitted to
intensive care units or explored in catheterization labs. A
total of 557 case patients were recruited. Diagnosis was
regarded as established if supported by electrocardiogra-
phy criteria and appropriate cardiac biomarkers, other-
wise diagnosis was considered as not definitively
confirmed. The controls selected for the case-control
study were participants free of coronary events being hos-
pitalized for health checkups in the same hospital during
the same period. The 1:2 matched controls (n = 1086)
were randomly selected from the participants, with
matching factors for age (50-60, 60-75, and > = 75 yrs),
sex, and LDL-C level (< 70, 70-100, 100-130 mg/dL).
Prospective cohort study
The second part of this study was a prospective cohort
study on the case patients. Information on mortality and
causes of death were obtained by linking the identifica-
tion numbers of the study subjects to a national data-
bank provided by the National Health Administration,
which was updated to the end of 2009. We defined all-
cause death according to the death codes from the 9
th
or 10
th versions of the International Classification of
Diseases (ICD).
Clinical and laboratory measurements
Data were collected family history, lifestyle habits, and
medical history, as well as anthropometric measurements,
such as body weight, and body height, when available.
Clinical variables were collected for each subject consisting
of measures of body mass index, lipid profiles, blood pres-
sures and glucose levels. Baseline hypertension and dia-
betes mellitus status were checked from the chart review.
Figure 3 Relationship between glomerular filtration rates and the risk of acute coronary syndrome event (left) and all-cause death
after event (right). The multivariate adjusted relative risks were plotted as a function of the baseline glomerular filtration rate with the 95%
confidence bands shown as the shaded area.
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nation as those within the first 8 hours following onset of
acute coronary syndrome. Lipid levels were measured in
the control participants when they received the health
checkup during the fasting status. Procedures for blood
sampling and analytic methods were the same in case
patients and control subjects and were performed as pre-
viously described [34]. In brief, serum total cholesterol
levels were measured using the CHOD-PAP method
(Boehringer Mannheim, Germany) while HDL-C was
measured following precipitation of apolipoprotein B-
containing lipoproteins, with phosphotungstic acid and
magnesium ions (Boehringer Mannheim, Germany)[35].
LDL-C levels were calculated if triglyceride levels were
below 400 mg/dL. Triglycerides concentrations were
measured by the GPO-DAOS method (Wako Co., Japan).
All of the biochemical measurements, including the
aforementioned lipid, uric acid, and creatinine concentra-
tions, were measured using a Hitachi 7450 automated
analyzer (Hitachi, Japan). All of the sample measurements
were carried out in a single hospital. The coefficients of
variation for the above measurements were around 5%.
Estimated glomerular filtration rates were calculated
from serum creatinine measurements with the abbre-
viated MDRD equation [36]:
eGFR (ml/min/1.73m2) = 186×[









All data were presented as mean and standard deviation
for continuous variables and contingency tables for cate-
gorical data, and were listed by status of case patient
and control subject. The t-test was used to test the dif-
ferences between case patients and control subjects. Par-
ticipants were categorized on the basis of quintiles of
HDL-C, triglycerides, LDL-C and estimated glomerular
filtration rate from the control subjects.
Multiple logistic regression models to adjust for
potentially confounding variables, including age, sex,
estimated glomerular filtration rate, body mass index
(continuous variable), alcohol intake (nondrinker/cur-
rent), smoking (yes/no), baseline hypertension (yes/no)
and type 2 diabetes mellitus (yes/no) were applied to
estimate the odds ratios and 95% confidence intervals
(CI) by quintiles of HDL-C and triglycerides. In addi-
tion, to test for linear trends across lipid marker cate-
gories, we used the median lipid profile levels within
quintiles as a continuous variable. Moreover, we exam-
ined whether the association between triglycerides and
acute coronary syndrome odds differed according to
weight status. Likelihood ratio tests were used to com-
pare the model with the interaction terms and the
model without the interaction terms. We also tested the
goodness-of-fit for the model by using the Hosmer and
Lemeshow test, [37] and the goodness-of-fit test was
acceptable. Finally, we conducted joint analyses to evalu-
ate potential additive associations of baseline HDL-C
and triglycerides using the tertiles in the control subjects
as the cutoff.
With regards to the cohort follow-up study, we con-
structed a multivariable Cox proportional hazards model
to incorporate possible clinical variables in one model.
To test the proportionality assumption in the Cox
regression model, we generated the time dependent cov-
ariates by creating interactions of the covariates and a
f u n c t i o no fs u r v i v a lt i m ea n di n c l u d e dt h e mi nt h eC o x
model [38]. The proportionality assumption for each
covariate and overall model in the multiple Cox model
were not rejected (all P values > 0.3).
In addition, we examined the non-linear relationship
between lipids as well as filtration rates and the risk of
coronary events and the survival non-parametrically
with restricted cubic splines [39]. Tests for non-linearity
used the likelihood ratio test, comparing the model with
only the linear term to the model with the linear and
the cubic spline terms. The relationships between lipids
and outcomes were plotted accordingly.
All statistical tests were two-tailed with a type I error
of 0.05, and P values < 0.05 were considered statistically
significant. Analyses were performed with SAS software
version 9.1 (SAS Institute, Cary, NC).
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